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Aim: Because it is a multistep process, in carcinogenesis it is necessary to determine key genes such as cyclin D1, p27, p21, bcl-2, and
p53 that are responsible for uncontrolled proliferation and other mechanisms. The aim of this study was to examine the correlation
between the anomalous accumulation of these proteins and the prognosis of laryngeal carcinomas.
Materials and methods: In our study, cyclin D1, p27, p21, bcl-2, and p53 expressions were analyzed immunohistochemically in
laryngeal squamous cell carcinomas, and the findings were compared with conventional prognostic parameters such as patient age,
sex, tumor localization and diameter, tumor differentiation, lymph node status, metastatic lymph node diameter, vascular and neural
invasion, clinical stage, and survival in 50 patients.
Results: Our results showed a statistically significant correlation between the presence of cyclin D1 expression and shorter survival in
patients with squamous cell carcinoma of the larynx. Patients with high p27 expression were found to have a higher risk of vascular
invasion, and patients with high bcl-2 expression were found to have a higher risk of cervical lymph node metastasis.
Conclusion: A negative correlation was found between cyclin D1 and survival, and a positive correlation was found between both p27
and bcl-2 and laryngeal squamous cell carcinoma prognosis.
Key words: Larynx, squamous cell carcinoma, cyclin D1, p21, p27, p53, bcl-2

1. Introduction
Squamous cell carcinoma is the most common malignancy
in the larynx (1). The prognosis of laryngeal cancer is
typically evaluated on the basis of a number of conventional
prognostic factors. Because it is a multistep process, in
carcinogenesis it is necessary to determine key genes such
as cyclin D1, p27, p21, bcl-2, and p53 that are responsible
for uncontrolled proliferation and other mechanisms (2).
Cyclin D1, p27, and p21 are cell cycle regulators; they
enable the cell to go through its normal cell cycle. bcl-2 is
the protooncogene that blocks apoptosis. p53 is a tumor
suppressor gene that has been claimed to play an essential
role in the pathogenesis of human tumors by affecting not
only the cell cycle but also apoptosis.
Many studies have examined the correlation between
the anomalous accumulation of those proteins and the

prognosis of laryngeal carcinomas, but conflicting results
have been obtained.
In our study, we analyzed the expression of cyclin
D1, p27, p21, bcl-2, and p53 immunohistochemically in
laryngeal squamous cell carcinomas. The findings were
compared with conventional prognostic parameters
such as age and sex of the patients, tumor localization
and diameter, tumor differentiation, lymph node status,
metastatic lymph node diameter, presence or absence of
vascular and neural invasion, clinical stage, and survival.
2. Materials and methods
2.1. Patient demographics and study protocols
A retrospective study was performed on 50 patients
with laryngeal squamous cell carcinoma who underwent
surgery with total laryngectomy and functional neck
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dissection at the ear, nose, and throat clinic of Ankara
Dışkapı Training & Research Hospital (formerly known as
SSK Ankara Training Hospital).
Patients’ age, sex, and clinical stage were noted
from the files; tumor localization and diameters, tumor
differentiation, vascular and neural invasion, lymph node
metastasis, and diameter of the metastatic lymph nodes
were reevaluated from glass slides. Distributions according
to tumor differentiation, tumor localization, and clinical
stage are shown in the Table.
Patients were followed for periods from 3 months to 4
years. Patients’ survivals were evaluated (median followup: 25.5 months).
2.2. Immunohistochemistry
All immunohistochemical analyses were performed
with the peroxidase–antiperoxidase technique. Paraffinembedded tissues were cut at 4–5 µm and dewaxed with
xylene. Antigen retrieval was performed with EDTA
solution for cyclin D1 antibody in a microwave oven
and with citrate solution for p27, p21, bcl-2, and p53 in a
pressure cooker.
Following the blocking of endogenous peroxidase
activity with 3% hydrogen peroxide, cyclin D1 (clone DCS6, Neomarker, 1/25), p27 (clone DCS-72.F6, Neomarker,
3/100), p21 (clone DCS-60.2, Neomarker, 3/100), bcl-2
(clone bcl-1/50/D5, Nova, 3/80), and p53 (clone DO7+BP53-12, Neomarker, 1/50) were employed. Tissues
then went through several steps of secondary antibody,
AEC chromogen, and Mayer’s hematoxylin.
Positive controls were selected as mantle cell lymphoma
for cyclin D1; as colon carcinoma for p27, p21, and p53;
and as normal tonsillar tissue for bcl-2. A negative control
was not studied.
2.3. Scoring of preparations
Both histopathological reevaluation and observation of
the immunohistochemical reactions were carried out
by 2 pathologists. The positivity of the antibodies was
determined by nuclear staining for cyclin D1, p27, p21, and
p53 and by granular cytoplasmic staining for bcl-2 protein
(Figures 1 and 2). Positivity with antibody was graded
according to the proportion of positive tumor cells in areas
where protein expression was more pronounced. A scale
of 0 to 4 was used to score the proportion of positive cells
with cyclin D1, p53, and bcl-2, with (0) indicating none
or less than 2% of cells positive; (1+), 2% to 25% of tumor
cells positive; (2+), 26% to 50% of tumor cells positive;
(3+), 51% to 75% of tumor cells positive; and (4+), 76%
to 100% of tumor cells positive. Patients were grouped for
analysis according to either low-expression (0–2+) (<50%)
or high-expression (3+–4+) (>50%) groups.
Immunohistochemical labeling of p27 and p21
antibodies was classified as positive when more than 5% of
nuclei were stained.
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2.4. Statistical analysis
The association of immunohistochemical expression
of individual proteins with patients’ age, sex, tumor
localization and diameter, tumor differentiation, vascular
and neural invasion, cervical lymph node metastasis,
clinical stage, and survival was determined by chi-square
analysis. The distribution of patient numbers according to
immunohistochemical expressions and the comparison
of them with clinicopathologic parameters are shown in
the Table. The associations of the immunohistochemical
expression of proteins with the diameters of the tumor and
metastatic lymph nodes were also examined by variance
analysis and t-test. Relative risk was measured for each
immunohistochemical parameter by a ‘risk estimate’ test.
Statistically significant cut-off values were not found for
immune markers.
3. Results
Only one patient was female in the study group (n = 50).
The distributions of age and other clinicopathological
parameters are shown in the Table.
Advanced stage tumors were presented in patients of
older age, and incidences of cervical lymph node metastasis
were found to be increased in older patients. Tumor
diameter was from 0.6 cm to 5 cm. Tumor localization and
diameter did not show any statistical significant difference
compared with other parameters.
Poorly differentiated tumors were presented in the
advanced stage, and the relationship was found to be
statistically significant (P = 0.00).
Lymph node metastasis was found to have a statistically
significant inverse correlation with survival (P = 0.00),
confirming the validity of the evaluation of lymph node
metastasis as a prognostic factor. Metastatic cervical
lymph nodes were found in 13 patients (26%). The biggest
metastatic lymph node was measured as 2.5 cm, and the
smallest was 1 cm in diameter. Metastatic lymph nodes
were also found in patients with advanced clinical stage
(P = 0.00).
Vascular invasion was found in 7 tumors (14%) and
was associated with advanced tumor stage (P = 0.00) and
cervical lymph node metastasis. Tumors with vascular
invasion almost always had neural invasion, which was
a statistically significant association (P = 0.00). A similar
correlation was found between survival and vascular
invasion.
Neural invasion was found in 3 patients (6%). There
was a statistically significant association between neural
invasion and metastatic lymph node diameter (P = 0.04).
If the metastatic lymph node had a diameter of more than
2 cm, it was more likely to have a neural invasion. Patients
who had tumors with neural invasion presented shorter
survival (P = 0.00).
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Table. Distribution of clinicopathological features of the study cases.
Case numbers

Percentage
(%)

4th decade

5

(10%)

5th decade

7

(14%)

6th decade

20

(40%)

7th decade

10

(20%)

8th decade

8

(16%)

Well

12

(24%)

Moderate

36

(72%)

Poor

2

(24%)

Supraglottic

35

(70%)

Glottic

10

(20%)

Subglottic

4

(8%)

Transglottic

1

(2%)

Stage 1

2

(4%)

Stage 2

17

(34%)

Stage 3

20

(40%)

Stage 4

11

(22%)

Positive

13 (0.5–2.5 cm)

(26%)

Negative

37

(74%)

Positive

7

(14%)

Negative

43

(86%)

Positive

3

(6%)

Negative

47

(94%)

Alive

35

(70%)

Deceased

15

(30%)

Median follow-up period

25.5 months

Clinicopathological features
Age

Tumor differentiation

Tumor localization

Clinical stage (TNM)

Metastatic cervical lymph node (+ size of the metastatic lymph node)

Vascular invasion

Neural invasion

Survival

3.1. Cyclin D1
Cyclin D1 expression was observed in 70% of tumors
(35/50 patients) (Figure 1 shows positive cyclin D1
expression of tumor). A statistically significant association
was found between cyclin D1 positivity and survival (P
= 0.043). There was a statistically borderline significance
between cyclin D1 expression and tumor differentiation (P
= 0.054).

3.2. p27
p27 was detected in 30% of the carcinomas (15/50 patients)
(Figure 2 shows positive p27 expression of tumor). Among
the cases with p27 positivity, the proportion of low
expressors was 96%. Lack of any statistically significant
association was observed between variables and detection
of p27. An analysis of relative risk using risk estimate
revealed higher vascular invasion in the higher p27

29

ŞİMŞEK et al. / Turk J Med Sci

lymph node metastasis (RR = 3.000), but this correlation
was not statistically significant (P = 0.456).
3.5. p53
Among 50 tumors, 26 were p53-positive. However, the
high expression ratio was only 22%.
We found no statistically significant association
between p53 expression and other protein expressions or
parameters.

Figure 1. High nuclear cyclin D1 expression in the squamous
carcinoma cells.

Figure 2. High nuclear p27 expression in the squamous
carcinoma cells.

expression group (RR = 7.000), although this relationship
was not statistically significant (P = 0.263).
3.3. p21
Patients with p21-positive tumors accounted for 20% of
the cases. In 98% of all cases, p21 was expressed in less
than 5% of neoplastic cells.
We found no statistically significant correlation between
p21 expression and other clinicopathological parameters.
3.4. bcl-2
bcl-2 was expressed in 10% of the patients. Among them,
a higher expression rate of bcl-2 was found (4%). Patients
with high bcl-2 expression had a higher risk of cervical
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4. Discussion
We settled the question of the presence or absence of a
correlation between the critical antiapoptotic cascade
proteins that occur in carcinogenesis and the prognosis of
squamous carcinoma of the larynx.
In the literature, most malignant lesions of the larynx are
squamous cell carcinomas that are localized in the glottic
region (approximately 60%) (3). Approximately 40% of
them are localized in the supraglottic area, and only 1% are
subglottic. In our study, 20% of the specimens were glottic
and 70% were supraglottic. Supraglottic carcinomas have
been reported to have the worst prognosis (3); however,
in our study tumor localization showed no correlation
with other parameters that we analyzed due to the small
number of subglottic and transglottic cases (10%).
In laryngeal carcinomas, the clinical stage determined
preoperatively is a prognostically important parameter
(1). In our series, this parameter also shows prognostic
relevance in tumor differentiation, neural and vascular
invasion, and lymph node metastasis.
A particularly important variable within TNM
classification is the presence of lymph node metastasis
(1,4–8). In our study, we found the presence of lymph
node metastasis to be significantly correlated with a
poor prognosis, which is consistent with the findings of
other studies (8,9). Additionally, there was a statistically
significant inverse correlation between lymph node
metastasis and survival (P = 0.00). We found a statistically
significant association between neural invasion and
metastatic lymph node diameter (P = 0.04).
Another commonly used prognostic criterion is
the degree of histologic differentiation. In our study,
differentiation was found to correlate with clinical stage.
This parameter was also studied in other studies and found
to be statistically significant in association with survival
(5,7).
Vascular and neural invasion are important parameters
that influence prognosis of cancer patients. Yılmaz et al.
found that these 2 parameters were associated significantly
with disease-free survival and recurrence of tumor (10).
In another study, perineural invasion was found to be
correlated with increased local recurrence and lymph
node metastasis (11). The results in our study corroborate
these findings.
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Although some of the conventional prognostic factors
that we have mentioned are used to predict the behavior of
a laryngeal tumor, some attempts have been made to find
some “biological” prognostic variables (12). Among these
are proteins such as cyclin D1, p27, p21, and p53, which
play a role in cell cycle control (13).
Cyclin D1 expressed in abnormally high concentrations
has found to be associated with a bad prognosis among
laryngeal tumors (14–17). In a study by Yoo et al. (14),
a statistically significant association was found between
cyclin D1 expression and local extension of the tumor.
However, these researchers found no correlation between
its expression and regional lymph node metastasis. Vielba
et al. (3) found no statistically significant association
between the overexpression of cyclin D1 and the survival
or disease-free interval of the patients. We found that
tumors with high expression of cyclin D1 presented
shorter survival times and poorly differentiated tumors
presented higher cyclin D1 expression; these relationships
were statistically significant. According to this analysis, the
variable most closely associated with survival was cyclin
D1, corroborating the results of many other studies.
In addition, we also investigated the relevance of
cell-cycle inhibitors such as p27 and p21 expression
by immunohistochemistry. Low levels of p27 and p21
expressions have been found to correlate with a poor
prognosis in lung, breast, prostate, gastric, bladder,
uterine, cervix, and endometrial carcinomas (18,19), but
their importance is still controversial in head and neck
cancers. A higher vascular invasion was shown in the
group with high expression of p27 (RR = 7.000), though
this relationship was not statistically significant. We found
no correlation of p21 expression with the parameters that
we analyzed.
It has been reported that in most cases, at least one of the
antiapoptosis genes is highly expressed in laryngeal cancer
(20). In our study, patients with high bcl-2 expression
had a higher risk of cervical lymph node metastasis, but

this correlation was not statistically significant. In the
literature, bcl-2 expression is usually associated with
chemotherapy response: a higher expression of bcl-2 is
said to correlate with a higher rate of complete response
(20). However, there are a number of examples of bcl-2
expression being nonpredictive, or of low levels of bcl-2
being associated with increased survival (20–23). In our
study, we found no statistically significant correlation of
bcl-2 protein expression with any other parameter.
The alteration of p53 has been the subject of a variety
of studies (24,25). There have been conflicting reports
regarding the clinical value of p53 analysis. In one study,
a statistically significant association was found between
a high expression of p53 and tumor differentiation (26).
In another study, no prognostic correlation was found
regarding the role of p53 (27). We found no statistically
significant association between p53 expression and other
protein expressions or parameters.
In conclusion, our results show a statistically significant
correlation between the presence of cyclin D1 expression
assessed by immunohistochemical analysis and shorter
survival in patients with squamous cell carcinoma of the
larynx, although this study comprises a small series of
patients without long-term follow-up and randomized
controls. Patients with high p27 expression were found to
have a higher risk of vascular invasion, and patients with
high bcl-2 expression were found to have a higher risk
of cervical lymph node metastasis, but these correlations
were not statistically significant. In our study, there was a
statistically significant inverse correlation between lymph
node metastasis and survival and a statistically significant
association (P = 0.04) between neural invasion and
metastatic lymph node diameter. Future studies with larger
series should be directed towards finding genetic defects in
laryngeal tumors and their correlation with conventional
prognostic factors, so that we can select what is likely to
be the most conservative, least morbid treatment for each
patient.
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